J. Nicholas O’Donnell

1.1k total citations
44 papers, 782 citations indexed

About

J. Nicholas O’Donnell is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, J. Nicholas O’Donnell has authored 44 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 21 papers in Epidemiology and 17 papers in Infectious Diseases. Recurrent topics in J. Nicholas O’Donnell's work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Antibiotic Resistance in Bacteria (17 papers) and Antimicrobial Resistance in Staphylococcus (15 papers). J. Nicholas O’Donnell is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (25 papers), Antibiotic Resistance in Bacteria (17 papers) and Antimicrobial Resistance in Staphylococcus (15 papers). J. Nicholas O’Donnell collaborates with scholars based in United States, United Kingdom and Australia. J. Nicholas O’Donnell's co-authors include Thomas P. Lodise, Nathaniel J. Rhodes, Marc H. Scheetz, Monique R. Bidell, Gwendolyn Pais, Walter C. Prozialeck, Anil Gulati, Jiajun Liu, Peter C. Lamar and Nimish Patel and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

J. Nicholas O’Donnell

42 papers receiving 775 citations

Peers

J. Nicholas O’Donnell
Elodie von Dach Switzerland
Yanina Dubrovskaya United States
Gilbert M. Rose United States
Ryan P. Mynatt United States
Kenneth Klinker United States
C Andrew DeRyke United States
Madiha Salim United States
Elodie von Dach Switzerland
J. Nicholas O’Donnell
Citations per year, relative to J. Nicholas O’Donnell J. Nicholas O’Donnell (= 1×) peers Elodie von Dach

Countries citing papers authored by J. Nicholas O’Donnell

Since Specialization
Citations

This map shows the geographic impact of J. Nicholas O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Nicholas O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Nicholas O’Donnell more than expected).

Fields of papers citing papers by J. Nicholas O’Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Nicholas O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Nicholas O’Donnell. The network helps show where J. Nicholas O’Donnell may publish in the future.

Co-authorship network of co-authors of J. Nicholas O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of J. Nicholas O’Donnell. A scholar is included among the top collaborators of J. Nicholas O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Nicholas O’Donnell. J. Nicholas O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butler, David A., Nimish Patel, J. Nicholas O’Donnell, & Thomas P. Lodise. (2024). Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature. Journal of Antimicrobial Chemotherapy. 79(10). 2421–2459. 5 indexed citations
2.
Lasek‐Nesselquist, Erica, Zhuo Ma, J. Nicholas O’Donnell, et al.. (2022). Phenotypic and genetic changes associated with the seesaw effect in MRSA strain N315 in a bioreactor model. Journal of Global Antimicrobial Resistance. 28. 249–253. 1 indexed citations
3.
Scheetz, Marc H., Gwendolyn Pais, Thomas P. Lodise, et al.. (2021). Of Rats and Men: a Translational Model To Understand Vancomycin Pharmacokinetic/Toxicodynamic Relationships. Antimicrobial Agents and Chemotherapy. 65(10). e0106021–e0106021. 10 indexed citations
4.
O’Donnell, J. Nicholas, Nathaniel J. Rhodes, Teresa Zembower, et al.. (2021). Impact of early antimicrobial stewardship intervention in patients with positive blood cultures: results from a randomized comparative study. International Journal of Antimicrobial Agents. 59(2). 106490–106490. 3 indexed citations
5.
O’Donnell, J. Nicholas, et al.. (2021). Effect of oral vancomycin dose on outcomes in patients with Clostridioides difficile infection. International Journal of Antimicrobial Agents. 57(4). 106311–106311.
6.
Avedissian, Sean N., Gwendolyn Pais, Jiajun Liu, et al.. (2020). The Pharmacodynamic-Toxicodynamic Relationship of AUC and C max in Vancomycin-Induced Kidney Injury in an Animal Model. Antimicrobial Agents and Chemotherapy. 65(3). 15 indexed citations
7.
O’Donnell, J. Nicholas, Allan Xu, & Thomas P. Lodise. (2020). Intravenous Compatibility of Ceftazidime–Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. Clinical Therapeutics. 42(8). 1580–1586.e2. 9 indexed citations
8.
O’Donnell, J. Nicholas, Nathaniel J. Rhodes, John S. Esterly, et al.. (2019). Assessment of mortality stratified by meropenem minimum inhibitory concentration in patients with Enterobacteriaceae bacteraemia: A patient-level analysis of published data. International Journal of Antimicrobial Agents. 55(2). 105849–105849. 4 indexed citations
9.
Avedissian, Sean N., Gwendolyn Pais, Jiajun Liu, et al.. (2019). 1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury. PubMed Central. 1 indexed citations
10.
Duprey, Matthew S., Nada S. Al‐Qadheeb, J. Nicholas O’Donnell, et al.. (2019). Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System. Drugs - Real World Outcomes. 6(3). 141–149. 5 indexed citations
11.
Rhodes, Nathaniel J., et al.. (2018). Resistance Trends and Treatment Options in Gram-Negative Ventilator-Associated Pneumonia. Current Infectious Disease Reports. 20(2). 3–3. 37 indexed citations
12.
Bidell, Monique R., Nimish Patel, & J. Nicholas O’Donnell. (2018). Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. Journal of Antimicrobial Chemotherapy. 73(10). 2643–2651. 37 indexed citations
13.
Rhodes, Nathaniel J., Jiajun Liu, J. Nicholas O’Donnell, et al.. (2017). Prolonged Infusion Piperacillin-Tazobactam Decreases Mortality and Improves Outcomes in Severely Ill Patients: Results of a Systematic Review and Meta-Analysis*. Critical Care Medicine. 46(2). 236–243. 83 indexed citations
14.
Rhodes, Nathaniel J., et al.. (2017). Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens. International Journal of Antimicrobial Agents. 50(3). 482–486. 22 indexed citations
15.
O’Donnell, J. Nicholas, Nathaniel J. Rhodes, Jiajun Liu, et al.. (2017). Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies. International Journal of Antimicrobial Agents. 51(2). 239–243. 22 indexed citations
16.
Crew, Page, Nathaniel J. Rhodes, J. Nicholas O’Donnell, et al.. (2017). Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection. American Journal of Infection Control. 46(3). 270–275. 6 indexed citations
17.
O’Donnell, J. Nicholas, et al.. (2017). Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosing. Journal of Infection and Chemotherapy. 23(5). 326–332. 2 indexed citations
18.
O’Donnell, J. Nicholas, Natarajan Venkatesan, Jack Chang, et al.. (2017). High‐Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin. Clinical and Translational Science. 10(6). 496–502. 13 indexed citations
19.
O’Donnell, J. Nicholas, et al.. (2016). Carbapenem susceptibility breakpoints, clinical implications with the moving target. Expert Review of Anti-infective Therapy. 14(4). 389–401. 8 indexed citations
20.
Cottreau, Jessica, David Thompson, J. Nicholas O’Donnell, et al.. (2015). Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia. PLoS ONE. 10(11). e0143845–e0143845. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026